Tanshinol suppresses cardiac allograft rejection in a murine model

Tanshinol suppresses cardiac allograft rejection by recruiting CD4+FoxP3+ Tregs to the graft, whereas rapamycin does so via expanding the Tregs. Thus, tanshinol cooperates with rapamycin to further extend cardiac allograft survival.